• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用苯并卟啉衍生物对脉络膜血管进行光动力闭塞。

The photodynamic occlusion of choroidal vessels using benzoporphyrin derivative.

作者信息

Lin S C, Lin C P, Feld J R, Duker J S, Puliafito C A

机构信息

Tufts University School of Medicine, Department of Ophthalmology, Boston, MA 02111.

出版信息

Curr Eye Res. 1994 Jul;13(7):513-22. doi: 10.3109/02713689408999883.

DOI:10.3109/02713689408999883
PMID:7523029
Abstract

We used benzoporphyrin derivative-monoacid (BPD-MA), a new photosensitizing agent, in photodynamic therapy (PDT) to occlude choroidal vessels in the rabbit. Using BPD-MA, seven dutch-belted rabbit eyes were photodynamically treated to achieve acute choroidal vessel closure. Fundoscopy, fluorescein angiography (FA), and histology were performed 1 hour, 1 day, 3 days, 7 days, 14 days, 21 days, and 28 days after PDT. On FA, PDT-treated spots remained nonperfused until day 3 when gradual reperfusion from the periphery began to appear. By day 28 the area of PDT appeared completely reperfused. Histology of lesions showed acute damage to choroidal vascular endothelial cells and retinal pigment epithelial (RPE) cells. Over subsequent days, recovery of RPE cells and regeneration of large choroidal vascular endothelial cells occurred. In addition, retinal degeneration occurred gradually over the 28 days of follow-up. Since current argon laser therapy of retinal neovascularization causes immediate retinal damage, the ability to occlude choroidal vessels without inducing acute thermal damage holds promise for treating clinical pathologic conditions that feature abnormal neovascularization, such as age-related macular degeneration and diabetic retinopathy.

摘要

我们使用新型光敏剂苯并卟啉衍生物单酸(BPD-MA)对兔脉络膜血管进行光动力疗法(PDT)闭塞治疗。使用BPD-MA对7只荷兰带兔眼进行光动力治疗以实现急性脉络膜血管闭塞。在光动力治疗后1小时、1天、3天、7天、14天、21天和28天进行眼底镜检查、荧光素血管造影(FA)和组织学检查。在荧光素血管造影上,光动力治疗的部位在第3天之前一直无灌注,之后从周边开始逐渐出现再灌注。到第28天时,光动力治疗区域似乎完全再灌注。病变的组织学检查显示脉络膜血管内皮细胞和视网膜色素上皮(RPE)细胞受到急性损伤。在随后的几天里,RPE细胞恢复,脉络膜大血管内皮细胞再生。此外,在28天的随访期间视网膜逐渐发生变性。由于目前氩激光治疗视网膜新生血管会立即造成视网膜损伤,在不引起急性热损伤的情况下闭塞脉络膜血管的能力有望用于治疗以异常新生血管形成为特征的临床病理状况,如年龄相关性黄斑变性和糖尿病性视网膜病变。

相似文献

1
The photodynamic occlusion of choroidal vessels using benzoporphyrin derivative.使用苯并卟啉衍生物对脉络膜血管进行光动力闭塞。
Curr Eye Res. 1994 Jul;13(7):513-22. doi: 10.3109/02713689408999883.
2
Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin.
Arch Ophthalmol. 1995 Jun;113(6):810-8. doi: 10.1001/archopht.1995.01100060136048.
3
Evaluation of the new photosensitizer Stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes.新型光敏剂Stakel(WST - 11)用于兔眼和大鼠眼光动力脉络膜血管闭塞的评估。
Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1633-44. doi: 10.1167/iovs.07-0767.
4
Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes.光动力疗法对人眼脉络膜和视网膜结构的剂量相关结构效应。
Graefes Arch Clin Exp Ophthalmol. 2002 Sep;240(9):748-57. doi: 10.1007/s00417-002-0517-4. Epub 2002 Aug 27.
5
Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment.使用维替泊芬的光动力疗法对治疗后长达7周的实验性脉络膜新生血管以及正常视网膜和脉络膜的影响。
Invest Ophthalmol Vis Sci. 1999 Sep;40(10):2322-31.
6
[Expression of angiogenic factors by photodynamic therapy].
Klin Monbl Augenheilkd. 2004 Dec;221(12):1026-32. doi: 10.1055/s-2004-813851.
7
Photodynamic therapy for polypoidal choroidal vasculopathy.光动力疗法治疗息肉样脉络膜血管病变。
Prog Retin Eye Res. 2013 Nov;37:182-99. doi: 10.1016/j.preteyeres.2013.09.003. Epub 2013 Oct 15.
8
Evaluation of the new photosensitizer Tookad (WST09) for photodynamic vessel occlusion of the choroidal tissue in rabbits.新型光敏剂Tookad(WST09)用于兔脉络膜组织光动力血管闭塞的评估。
Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5437-46. doi: 10.1167/iovs.06-0532.
9
Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization.静脉输注脂质体苯并卟啉衍生物用于实验性脉络膜新生血管的光动力治疗。
Arch Ophthalmol. 1996 Aug;114(8):978-85. doi: 10.1001/archopht.1996.01100140186012.
10
Photodynamic therapy for choriocapillaris using tin ethyl etiopurpurin (SnET2).使用二乙氧锡卟吩(SnET2)对脉络膜毛细血管进行光动力疗法。
Ophthalmic Surg Lasers. 1997 May;28(5):409-17.

引用本文的文献

1
Large animal models for investigating the applications of photodynamic therapy.用于研究光动力疗法应用的大型动物模型。
Zool Res. 2025 May 18;46(3):551-575. doi: 10.24272/j.issn.2095-8137.2024.445.
2
Neuropilin-1 targeting photosensitization-induced early stages of thrombosis via tissue factor release.神经纤毛蛋白-1 靶向光动力诱导的组织因子释放引发血栓形成的早期阶段。
Pharm Res. 2010 Mar;27(3):468-79. doi: 10.1007/s11095-009-0035-8. Epub 2010 Jan 20.
3
Video monitoring of neovessel occlusion induced by photodynamic therapy with verteporfin (Visudyne), in the CAM model.
在鸡胚绒毛尿囊膜(CAM)模型中,使用维替泊芬(Visudyne)进行光动力疗法诱导新生血管闭塞的视频监测。
Angiogenesis. 2008;11(3):235-43. doi: 10.1007/s10456-008-9106-4. Epub 2008 Mar 7.
4
Clinicopathological findings of choroidal neovascularisation following verteporfin photodynamic therapy.维替泊芬光动力疗法后脉络膜新生血管形成的临床病理研究结果
Br J Ophthalmol. 2004 Feb;88(2):207-11. doi: 10.1136/bjo.2003.018754.
5
Verteporfin.维替泊芬
Drugs Aging. 2000 Feb;16(2):139-46; discussion 147-8. doi: 10.2165/00002512-200016020-00005.
6
Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD).使用苯并卟啉衍生物(BPD)进行光动力治疗后急性血管损伤的分析。
Br J Cancer. 1999 Apr;79(11-12):1702-8. doi: 10.1038/sj.bjc.6690271.
7
Science, medicine, and the future. New techniques in laser therapy.科学、医学与未来。激光治疗新技术。
BMJ. 1998 Mar 7;316(7133):754-7. doi: 10.1136/bmj.316.7133.754.